Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma

Name: GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma — clinical trial record (NCT07852975)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GLAD-KE

StatusNot Yet Recruiting

PhaseNot applicable

SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Started2026-10-15

View on ClinicalTrials.gov ↗

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

135 trials monitored

See 15 trials at risk

Glioblastoma

666 trials monitored

See 45 trials at risk

Glioma

666 trials monitored

See 38 trials at risk

This study is being done to see if a Ketogenic Diet (KD) or short-term Ketone supplement (KS) is feasible and safe for patients with recurrent Glioma who are undergoing a clinically indicated surgery.

Trial Details

NCT Number	NCT07852975
Lead Sponsor	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Collaborators: Ludwig Institute for Cancer Research, Kenetik
Conditions	Recurrent Glioma (Glioblastoma Multiforme)
Enrollment	20 participants
Start Date	2026-10-15
Primary Completion	2029-10-15 (estimated)
Study Completion	2030-10-15 (estimated)
Updated on ClinicalTrials.gov	2026-10-01